Researchers at the University of Gothesburg in Sweden have discovered that, by analyzing spinal fluid from a patient, it may be possible to detect Alzheimer's disease much earlier than normal. This is through the use of biomarkers in proteins and peptides.
"We measured levels of the biomarkers in the spinal fluid and found that high levels of these substances confirmed the diagnosis of Alzheimer's with a high degree of accuracy compared with levels in healthy controls and patients with other forms of dementia," researcher Johan Svensson said in a statement.
This could be a groundbreaking advancement for Alzheimer's treatment, because being able to confidently diagnose the disease early on can lead to better preventative and safety measures for patients. Families could also help plan for the disease better by installing a senior alert system in an older adult's residence. This device enables users to immediately send a medical alert in the case of an emergency.
The Alzheimer's Association has estimated that the baby boomer generation will be widely affected by the disease, as one in eight will develop it in old age.